Abstract
In this study, we report on three Japanese patients with cytochrome P450 oxidoreductase (POR) deficiency (PORD). Case one was a 46,XY patient who was found to have mildly increased 17α-hydroxyprogesterone (17-OHP) by the neonatal mass screening. There was no maternal virilization during pregnancy, and he had no skeletal or genital abnormality. Thus, he was initially diagnosed as having nonclassical 21-hydroxylase deficiency (21-OHD). Cases two and three were 46,XX patients who were identified because of severely virilized external genitalia and maternal virilization during pregnancy. In case two, the neonatal mass screening was normal, and she had no skeletal abnormality except for mild adduction of bilateral third toes. Thus, she was initially diagnosed as having aromatase deficiency. In case three, the neonatal mass screening showed moderately increased 17-OHP, and no skeletal lesion other than rigid second metacarpophalangeal joints was identified in early infancy. Thus, she was initially suspected as having 21-OHD and/or aromatase deficiency. Subsequently, endocrine studies including urine steroid hormone analysis were performed for the assessment of glucocorticoid treatment in case one and for the virilized genitalia in cases two and three, showing adrenal and/or gonadal dysfunction characteristic of PORD. Thus, molecular analysis of POR was carried out, demonstrating homozygosity for R457H in cases one through three. The results imply that clinical features in PORD can be similar to those in 21-OHD or aromatase deficiency, and that comprehensive assessment of the pregnant course, physical examination, and adrenal and gonadal function studies is essential for the precise diagnosis of PORD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ABS:
-
Antley-Bixler syndrome
- Δ4A:
-
androstenedione
- DHEA:
-
dehydroepiandrosterone
- DOF:
-
deoxycortisol
- E3:
-
estriol
- M(s):
-
metabolite(s)
- PCO:
-
polycystic ovary
- POR:
-
cytochrome P450 oxidoreductase
- PORD:
-
cytochrome P450 oxidoreductase deficiency
- T:
-
testosterone
- 17-OHP:
-
17α-hydroxyprogesterone
- 21-OHD:
-
21-hydroxylase deficiency
References
Flück CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonca BB, Fujieda K, Miller WL 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36: 228–230
Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363: 2128–2135
Miller WL 2004 P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations. Trends Endocrinol Metab 15: 311–315
Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, Sato N, Okuyama T, Nakai H, Soneda S, Tachibana K, Matsuo N, Sato S, Homma K, Nishimura G, Hasegawa T, Ogata T 2005 Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90: 414–426
Cragun DL, Trumpy SK, Shackleton CH, Kelley RI, Leslie ND, Mulrooney NP, Hopkin RJ 2004 Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome. Am J Med Genet A 129: 1–7
Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Fluck CE, Miller WL 2005 Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76: 729–749
Stewart PM 2002 The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology. 10th ed. Saunders, Philadelphia 491–551 pp
Shozu M, Akasofu K, Harada T, Kubota Y 1991 A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 72: 560–566
Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER 1994 A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 78: 1287–1292
Miller WL 2001 The adrenal cortex and its disorders. In: Brook CGD, Hindmarsh PC, Jacobs HS (eds) Clinical Pediatric Endocrinology. 4th ed. Blackwell Science, Oxford pp 321–376
Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, Di Martino-Nardi J, Reiter E 1991 Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 73: 674–686
Lashansky G, Saenger P, Dimartino-Nardi J, Gautier T, Mayes D, Berg G, Reiter E 1992 Normative data for the steroidogenic response of mineralocorticoids and their precursors to adrenocorticotropin in a healthy pediatric population. J Clin Endocrinol Metab 75: 1491–1496
Hasegawa Y 2003 Normal range of GnRH stimulation test. In: Hasegawa Y (ed) Let's enjoy pediatric endocrinology. 3rd ed. Sindan-to-tiryou-sha, Tokyo, Japan pp 260–262
Kreutzmann DJ, Cowell CT, Howard NJ, De Souza M, Silink M 1989 Congenital adrenal hyperplasia family studies using the short ACTH test. Aust Paediatr J 25: 340–345
Homma K, Hasegawa T, Masumoto M, Takeshita E, Watanabe K, Chiba H, Kurosawa T, Takahashi T, Matsuo N 2003 Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring. Endocr J 50: 783–792
New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS 1983 Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57: 320–326
Adachi M, Tachibana K, Asakura Y, Yamamoto T, Hanaki K, Oka A 2004 Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet 128: 333–339.
Grumbach MM, Hughes IA, Conte FA 2002 Disorders of sex differentiation. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. 10th ed. Saunders, Philadelphia pp 842–1002
Auchus RJ 2004 The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 15: 432–438
Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, Shaw G, Renfree MB 2003 5alpha-androstane-3alpha, 17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha, 17alpha-diol-20-one as a key intermediate. Endocrinology 144: 575–580
Shackleton C, Marcos J, Arlt W, Hauffa BP 2004 Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A 129: 105–112
Shackleton C, Marcos J, Malunowicz EM, Szarras-Czapnik M, Jira P, Taylor NF, Murphy N, Crushell E, Gottschalk M, Hauffa B, Cragun DL, Hopkin RJ, Adachi M, Arlt W 2004 Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet A 128: 223–231
Nimkarn S, Cerame BI, Wei JQ, Dumic M, Zunec R, Brkljacic L, Skrabic V, New MI, Wilson RC 1999 Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab 84: 378–381
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant for Child Health and Development from the Ministry of Health, Labor, and Welfare (17C-2), and by a Grant-in-Aid for Scientific Research on Priority Areas (16086215).
Rights and permissions
About this article
Cite this article
Fukami, M., Hasegawa, T., Horikawa, R. et al. Cytochrome P450 Oxidoreductase Deficiency in Three Patients Initially Regarded as Having 21-Hydroxylase Deficiency and/or Aromatase Deficiency: Diagnostic Value of Urine Steroid Hormone Analysis. Pediatr Res 59, 276–280 (2006). https://doi.org/10.1203/01.pdr.0000195825.31504.28
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000195825.31504.28
This article is cited by
-
Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature
Journal of Endocrinological Investigation (2022)
-
Regulation of P450 oxidoreductase by gonadotropins in rat ovary and its effect on estrogen production
Reproductive Biology and Endocrinology (2008)
-
P450 oxidoreductase deficiency and Antley–Bixler syndrome
Reviews in Endocrine and Metabolic Disorders (2007)
